PA8469001A1 - Combinaciones de estatina-inhibidor de mmp. - Google Patents
Combinaciones de estatina-inhibidor de mmp.Info
- Publication number
- PA8469001A1 PA8469001A1 PA19998469001A PA8469001A PA8469001A1 PA 8469001 A1 PA8469001 A1 PA 8469001A1 PA 19998469001 A PA19998469001 A PA 19998469001A PA 8469001 A PA8469001 A PA 8469001A PA 8469001 A1 PA8469001 A1 PA 8469001A1
- Authority
- PA
- Panama
- Prior art keywords
- statin
- mmp
- inhibitor combinations
- inhibitor
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ESTA INVENCION ES UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN INHIBIDOR DE MMP Y UNA ESTATINA, DICHA COMPOSICION ES UTIL PARA TRATAR ENFERMEDADES VASCULARES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7826598P | 1998-03-17 | 1998-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8469001A1 true PA8469001A1 (es) | 2002-09-17 |
Family
ID=22142950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA19998469001A PA8469001A1 (es) | 1998-03-17 | 1999-03-16 | Combinaciones de estatina-inhibidor de mmp. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1063991A1 (es) |
JP (1) | JP2002506818A (es) |
KR (1) | KR20010041916A (es) |
AR (1) | AR018113A1 (es) |
AU (1) | AU1591699A (es) |
BR (1) | BR9815745A (es) |
CA (1) | CA2309588A1 (es) |
CO (1) | CO5070670A1 (es) |
GT (1) | GT199900039A (es) |
HN (1) | HN1999000029A (es) |
MY (1) | MY140504A (es) |
NZ (1) | NZ505994A (es) |
PA (1) | PA8469001A1 (es) |
PE (1) | PE20000348A1 (es) |
SV (1) | SV1999000026A (es) |
UY (1) | UY25436A1 (es) |
WO (1) | WO1999047138A1 (es) |
ZA (1) | ZA992106B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0100761D0 (en) | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
CA2590278A1 (en) | 2004-12-15 | 2006-06-22 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors |
AU2006313430B2 (en) * | 2005-11-08 | 2012-09-06 | Ranbaxy Laboratories Limited | Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
US20110182851A1 (en) * | 2008-07-11 | 2011-07-28 | Jan Nilsson | Oxidized ldl specific antibody-fusion and conjugated proteins |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE348607T1 (de) * | 1995-11-02 | 2007-01-15 | Warner Lambert Co | Verfahren und pharmazeutische zusammensetzung zur regelung der lipidkonzentration |
JP2000511175A (ja) * | 1996-05-17 | 2000-08-29 | ワーナー―ランバート・コンパニー | ビフェニルスルホンアミドマトリックスメタロプロテイナーゼ阻害剤 |
NZ334897A (en) * | 1996-12-09 | 2001-02-23 | Warner Lambert Co | Medicaments for treating and preventing heart failure and ventricular dilatation |
TW536540B (en) * | 1997-01-30 | 2003-06-11 | Bristol Myers Squibb Co | Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe |
GT199800126A (es) * | 1997-08-29 | 2000-01-29 | Terapia de combinacion. |
-
1998
- 1998-11-20 WO PCT/US1998/024681 patent/WO1999047138A1/en not_active Application Discontinuation
- 1998-11-20 JP JP2000536378A patent/JP2002506818A/ja active Pending
- 1998-11-20 KR KR1020007010223A patent/KR20010041916A/ko not_active Application Discontinuation
- 1998-11-20 NZ NZ505994A patent/NZ505994A/xx unknown
- 1998-11-20 CA CA002309588A patent/CA2309588A1/en not_active Abandoned
- 1998-11-20 AU AU15916/99A patent/AU1591699A/en not_active Abandoned
- 1998-11-20 BR BR9815745-0A patent/BR9815745A/pt not_active Application Discontinuation
- 1998-11-20 EP EP98960279A patent/EP1063991A1/en not_active Withdrawn
-
1999
- 1999-02-24 AR ARP990100751A patent/AR018113A1/es unknown
- 1999-03-15 MY MYPI99000951A patent/MY140504A/en unknown
- 1999-03-16 HN HN1999000029A patent/HN1999000029A/es unknown
- 1999-03-16 ZA ZA9902106A patent/ZA992106B/xx unknown
- 1999-03-16 GT GT199900039A patent/GT199900039A/es unknown
- 1999-03-16 PE PE1999000217A patent/PE20000348A1/es not_active Application Discontinuation
- 1999-03-16 PA PA19998469001A patent/PA8469001A1/es unknown
- 1999-03-16 SV SV1999000026A patent/SV1999000026A/es not_active Application Discontinuation
- 1999-03-16 UY UY25436A patent/UY25436A1/es not_active Application Discontinuation
- 1999-03-16 CO CO99016109A patent/CO5070670A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
GT199900039A (es) | 2000-09-06 |
HN1999000029A (es) | 1999-09-29 |
AU1591699A (en) | 1999-10-11 |
CA2309588A1 (en) | 1999-09-23 |
MY140504A (en) | 2009-12-31 |
NZ505994A (en) | 2003-10-31 |
CO5070670A1 (es) | 2001-08-28 |
ZA992106B (en) | 1999-09-30 |
WO1999047138A1 (en) | 1999-09-23 |
UY25436A1 (es) | 2001-10-25 |
SV1999000026A (es) | 2000-01-18 |
JP2002506818A (ja) | 2002-03-05 |
BR9815745A (pt) | 2000-11-14 |
PE20000348A1 (es) | 2000-05-22 |
EP1063991A1 (en) | 2001-01-03 |
KR20010041916A (ko) | 2001-05-25 |
AR018113A1 (es) | 2001-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8506101A1 (es) | Uso de un compuesto acat para fabricar una composicion farmaceutica | |
ES2161548T3 (es) | Combinacion de un inhibidor de la aldosa reductasa y un inhibidor de la glucogeno fosforilasa. | |
ES2176755T3 (es) | Derivados anticonvulsivos utiles para el tratamiento de la esclerosis lateral amiotrofica. | |
HN2003000227A (es) | Inhibidores de quinasas | |
GT200100156A (es) | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de colesteril ester. | |
BR9809819A (pt) | Compostos e métodos para a inibição da expressão de vcam-1 | |
PA8564901A1 (es) | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo | |
PT1105122E (pt) | Composicoes farmaceuticas que contem inibidores de lipase | |
ES2178298T3 (es) | Compuestos anti-inflamatorios. | |
UY25714A1 (es) | Método para tratar ateroesclerosis empleando un inhibidor de ap2 y combinación. | |
ES2182874T3 (es) | Procedimiento de tratamiento de las uñas. | |
ES2184340T3 (es) | Combinaciones de inhibidores de la enzima de conversion de la angiotensina e inhibidores de la enzima metaloproteinasa matricial. | |
PT1032414E (pt) | Combinacao de um inibidor da enzima de conversao da angiotensina e de um diuretico para o tratamento de perturbacoes microcirculatorias | |
GT199800177A (es) | Combinacion eficaz para el tratamiento de la impotencia . | |
MEP64008A (en) | Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis | |
AU2003296807A1 (en) | Cosmetic composition comprising a metalloproteinase inhibitor and a lipopeptide | |
AR015837A1 (es) | Metodo de transformacion de plantas. | |
CU20000140A7 (es) | Combinaciones de estatina-carboxialquileter | |
MA26486A1 (fr) | Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant . | |
HN2003000071A (es) | Combinaciones de un ligando alfa-2-delta con un inhibidor selectivo de la ciclooxigenasa-2 | |
PA8469001A1 (es) | Combinaciones de estatina-inhibidor de mmp. | |
ES2132539T3 (es) | Composiciones insecticidas sinergicas. | |
BR9808923B1 (pt) | processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2. | |
BR0108980A (pt) | Aplicação e formulação farmacêuticas compreendendo inibidor de reabsorção de norepinefrina | |
GT200200244A (es) | Composicion intensiva de herbicida |